Bacillus sp. DU-106 ameliorates type 2 diabetes by modulating gut microbiota in high-fat-fed and streptozotocin-induced mice
- PMID: 35951725
- DOI: 10.1111/jam.15773
Bacillus sp. DU-106 ameliorates type 2 diabetes by modulating gut microbiota in high-fat-fed and streptozotocin-induced mice
Abstract
Aims: Type 2 diabetes (T2D) is a chronic disease that manifests as endocrine and metabolic disorders that seriously threatening public health. This study aimed to investigate the effects of Bacillus sp. DU-106 on anti-diabetic effects and gut microbiota in C57BL/6J mice fed a high-fat diet and streptozotocin-induced T2D.
Methods and results: Bacillus sp. DU-106 was administered to model mice for eight consecutive weeks. Oral administration of Bacillus sp. DU-106 decreased food and water intake and alleviated body weight loss. Moreover, Bacillus sp. DU-106 imparted several health benefits to mice, including balanced blood glucose, alleviation of insulin resistance in T2D mice and an improvement in lipid metabolism. Furthermore, Bacillus sp. DU-106 protected against liver and pancreatic impairment. Additionally, Bacillus sp. DU-106 treatment reshaped intestinal flora by enhancing gut microbial diversity and enriching the abundance of certain functional bacteria.
Conclusion: Collectively, these findings suggest that Bacillus sp. DU-106 can ameliorate T2D by regulating the gut microbiota.
Significance and impact of study: Therefore, a novel probiotic, Bacillus sp. DU-106 may be a promising therapeutic agent for improving and alleviating T2D in mice.
Keywords: Bacillus sp. DU-106; gut microbiota; hyperglycaemic; metformin; probiotics; type 2 diabetes.
© 2022 Society for Applied Microbiology.
References
REFERENCES
-
- Abdellatif, A.M. & Sarvetnick, N.E. (2019) Current understanding of the role of gut dysbiosis in type 1 diabetes. Journal of Diabetes, 11, 632-644.
-
- Cao, Y., Chen, X., Sun, Y., Shi, J., Xu, X. & Shi, Y.C. (2018) Hypoglycemic effects of pyrodextrins with different molecular weights and digestibilities in mice with diet-Induced obesity. Journal of Agricultural and Food Chemistry, 66, 2988-2995.
-
- Chen, C., You, L.J., Huang, Q., Fu, X., Zhang, B., Liu, R.H. et al. (2018) Modulation of gut microbiota by mulberry fruit polysaccharide treatment of obese diabetic db/db mice. Food & Function, 9, 3732-3742.
-
- Chen, P., Zhang, Q., Dang, H., Liu, X., Tian, F., Zhao, J. et al. (2014) Oral administration of Lactobacillus rhamnosus CCFM0528 improves glucose tolerance and cytokine secretion in high-fat-fed, streptozotocin-induced type 2 diabetic mice. Journal of Functional Foods, 10, 318-326.
-
- De Vadder, F., Kovatcheva-Datchary, P., Goncalves, D., Vinera, J., Zitoun, C., Duchampt, A. et al. (2014) Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits. Cell, 156, 84-96.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
